Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis

被引:79
作者
Bax, JJ
Schinkel, AFL
Boersma, E
Elhendy, A
Rizzello, V
Maat, A
Roelandt, JRTC
van der Wall, EE
Poldermans, D
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, NL-2333 ZA Leiden, Netherlands
[2] ThoraxCtr, Dept Cardiol, Rotterdam, Netherlands
[3] ThoraxCtr, Dept Epidemiol & Stat, Rotterdam, Netherlands
[4] ThoraxCtr, Dept Thorac Surg, Rotterdam, Netherlands
关键词
myocardial viability; hibernating myocardium; heart failure; left ventricle remodeling; surgical revascularization;
D O I
10.1161/01.CIR.0000138195.33452.b0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Extensive left ventricular (LV) remodeling may not allow functional recovery after revascularization, despite the presence of viable myocardium. Methods and Results-Seventy-nine consecutive patients with ischemic cardiornyopathy (left ventricle ejection fraction [LVEF] 29 +/- 7%) underwent surgical revascularization. Before revascularization, viability was assessed by metabolic imaging with F18-fluorodeoxyglucose and SPECT. LV volumes and LVEF were assessed by resting echocardiography. LVEF was re-assessed by echocardiography 8 to 12 months after revascularization. Three-year clinical follow-up (events: cardiac death, infarction, and hospitalization for heart failure) was also obtained. Forty-nine patients had substantial viability; 5 died before re-assessment of LVEF. Of the remaining 44 patients, 24 improved greater than or equal to5% in LVEF after revascularization, whereas 20 did not improve in LVEF. LV end-systolic volume was the only parameter that was significantly different between the groups (109 +/- 46 mL for the improvers versus 141 +/- 31 mL for the nonimprovers; P<0.05). The change in LVEF after revascularization was linearly related to the baseline LV end-systolic volume, with a higher LV end-systolic volume associated with a low likelihood of improvement in LVEF after revascularization. During the 3-year follow-up, the highest event-rate (67%) was observed in patients without viable myocardium with a large LV size, whereas the lowest event rate (5%) was observed in patients with viable myocardium and a small LV size. Intermediate event rates were observed in patients with viable myocardium and a large LV size (38%), and in patients without viable myocardium and a small LV size (24%). Conclusion-Extensive LV remodeling prohibits improvement in LVEF after revascularization and affects long-term prognosis negatively, despite the presence of viability.
引用
收藏
页码:II18 / II22
页数:5
相关论文
共 16 条
[1]   Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis [J].
Allman, KC ;
Shaw, LJ ;
Hachamovitch, R ;
Udelson, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1151-1158
[2]  
Bax JJ, 2001, J NUCL MED, V42, P79
[3]  
Bax JJ, 2001, CURR PROB CARDIOLOGY, V26, P147, DOI [DOI 10.1067/MCD.2001.109973, 10.1067/mcd.2001.109973]
[4]   F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function [J].
Beanlands, RSB ;
deKemp, RA ;
Smith, S ;
Johansen, H ;
Ruddy, TD .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (08) :1092-&
[5]   Extent of myocardial viability in regions of left ventricular dysfunction by rest-redistribution thallium-201 imaging: A powerful predictor of outcome [J].
Beller, GA ;
Ragosta, M .
JOURNAL OF NUCLEAR CARDIOLOGY, 1998, 5 (04) :445-448
[6]   Myocardial viability and prognosis in patients with ischemic left ventricular dysfanction [J].
Bonow, RO .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1159-1162
[7]   An estimate of the prevalence of reversible left ventricular dysfunction in patients referred for coronary artery bypass surgery [J].
Christian, TF ;
Miller, TD ;
Hodge, DO ;
Orszulak, TA ;
Gibbons, RJ .
JOURNAL OF NUCLEAR CARDIOLOGY, 1997, 4 (02) :140-146
[8]  
KNUUTI MJ, 1994, J NUCL MED, V35, P989
[9]  
LOUIE HW, 1991, CIRCULATION, V84, P290
[10]   The viable myocardium: epidemiology, detection, and clinical implications [J].
Marwick, TH .
LANCET, 1998, 351 (9105) :815-819